Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Revenue and Financial Performance
BAX logo

Baxter International Pivots After $3.2 Billion Divestiture Amid 500 Basis Point Margin Contraction

BAX10-QFiling Date: 4/30/2026
Baxter International Inc.
Description

What this story covers

Baxter International navigates a major transition after its Kidney Care divestiture. Despite international growth, the company faces organic declines, regulatory holds, and margin pressure from inflation and supply chain issues. Liquidity is solid, but debt remains a focus.

Story snapshot

CompanyBaxter International Inc.
TickerBAX
VariantStandard detailed
Duration10:29
Filing type10-Q
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001628280-26-028962
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in